Liquid biopsy can cure early colorectal cancer recurrence – Case Report

In the context of colorectal cancer (CRC), circulating tumor DNA (ctDNA) is frequently used to monitor the minimal residual disease (MRD). ctDNA has become an excellent biomarker to predict which patients with CRC are likely to relapse due to the persistence of micrometastases. MRD diagnosis via ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Baraniskin, Alexander, Baba, Hideo A., Theegarten, Dirk, Mika, Thomas, Schroers, Roland, Klein-Scory, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188995/
https://www.ncbi.nlm.nih.gov/pubmed/37207159
http://dx.doi.org/10.3389/fonc.2023.1141833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188995/
https://www.ncbi.nlm.nih.gov/pubmed/37207159
http://dx.doi.org/10.3389/fonc.2023.1141833

Ejemplares similares